YARTEMLEA
Live / Registered — Registered (as of 04 Jul 2023)
What this means for you
Registered since 04 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88453133
- Registration number
- 7101138
- Mark type
- Stylized text
- Filed
- 30 May 2019
- Published for opposition
- 07 Apr 2020
- Registered
- 04 Jul 2023
- Attorney of record
- Kelley B. Harrington
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders
Owner
- Omeros Corporation, Seattle, WA, US
- Omeros Corporation, Seattle, WA, US
- Omeros Corporation, Seattle, WA, US
Prosecution history
- 14 Nov 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 25 May 2023 — USE AMENDMENT FILED
- 25 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 02 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2022 — SOU EXTENSION 5 GRANTED